Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement
“Negative” Patent Claim Limitations—May They be Adequately Described by Omission?
New York Broadens the Scope of Admissible Employee Statements
“About-Face” Representations to FDA Will Be Used Against You
“About-Face” Representations to FDA Will Be Used Against You
Update on Artificial Intelligence: Court Rules that AI Cannot Qualify As “Inventor”
Beware the Privilege Waiver During Investor Due Diligence
Defendants in Vineyard Vines Trademark Dispute Hit with Liquidated Damages and Attorneys’ Fees
